We are live on ! Find out more
INDP icon

Indaptus Therapeutics
INDP

10 hedge funds and large institutions have $2.31M invested in Indaptus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% less capital invested

Capital invested by funds: $2.98M → $2.31M (-$673K)

41% less funds holding

Funds holding: 17 → 10 (-7)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

88% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 8

Holders
10
Holders Change
-7
Holders Change %
-41.18%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$133K
2
Squarepoint
Squarepoint
New York
+$75.3K

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$179K
2
SM
Sabby Management
Florida
-$164K
3
Bank of America
Bank of America
North Carolina
-$138K
4
Goldman Sachs
Goldman Sachs
New York
-$116K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$65K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
AdvisorShares Investments
Maryland
$1.54M – – –
MIH
2
Meitav Investment House
Israel
$420K – – –
Morgan Stanley
3
Morgan Stanley
New York
$121K +$133K +301 +3,010%
GCP
4
GSA Capital Partners
United Kingdom
$116K -$53.7K -122 -29%
Squarepoint
5
Squarepoint
New York
$67K +$75.3K +171 New
Citadel Advisors
6
Citadel Advisors
Florida
$43K -$39.6K -90 -45%
Wells Fargo
7
Wells Fargo
California
$1K -$11.9K -27 -93%
Osaic Holdings
8
Osaic Holdings
Arizona
$1K – – –
CS
9
Credit Suisse
Switzerland
– -$179K -365 Closed
SM
10
Sabby Management
Florida
– -$164K -335 Closed
Bank of America
11
Bank of America
North Carolina
– -$138K -283 Closed
Goldman Sachs
12
Goldman Sachs
New York
– -$116K -238 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
– -$65K -135 Closed
TSS
14
Two Sigma Securities
New York
– -$50K -102 Closed
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
– -$4K -9 Closed
SFS
16
Sowell Financial Services
Arkansas
– -$3K -8 Closed

INDP Hedge Fund Activity: Q2 2021 in Review

10 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q2 2021, worth a combined $2.31M — down 23% from $2.98M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of INDP and 1 opened new positions — a net loss of 7 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, adding an estimated $133K. The largest seller was Credit Suisse, exiting entirely with an estimated $179K sold.

  • 10 institutional investors held Indaptus Therapeutics (INDP) as of Q2 2021, down from 17 in Q1 2021.
  • Funds reported $2.31M of Indaptus Therapeutics stock for Q2 2021, down 23% quarter-over-quarter.
  • 1 fund opened new Indaptus Therapeutics positions in Q2 2021 and 8 closed out, a net change of -7 holders.
  • The largest Indaptus Therapeutics buyer in Q2 2021 was Morgan Stanley, an estimated $133K added.
  • The largest Indaptus Therapeutics seller in Q2 2021 was Credit Suisse, an estimated $179K sold.

Based on aggregated 13F filings for Q2 2021.